微信二维码

OUR PORTFOLIO

Oxford Nanopore
Auris Health
Potrero
BJ Bioscience
GI Windows Surgical
Exscientia
Apeiron
Boundless Bio

Collaborators

Oxford Sciences Innovation (OSI)

Based in Oxford, England, Oxford Sciences Innovation (OSI) specializes in investments in spin-outs from Oxford University’s technology, mathematical, physical, life sciences and medical sciences departments.

Oxford Nanopore Technologies

Oxford Nanopore’s goal is to enable the analysis of any living thing, by anyone,anywhere. The Company has developed the world's first and only nanopore DNA sequencing platform, which is uniquely scalable from pocket-sized formats through to ultra-high throughput devices.

Oxford Investment Consultants LLP

Oxford Investment Consultants LLP is an investment advisor that covers life sciences, healthcare and technology in the United Kingdom. The firm prefers to make investments in the University of Oxford spin out companies. Oxford Investments Consultants LLP is based in the United Kingdom.

CONTACT US

Latest information

Boundless Bio Announces $100 Million Oversubscribed Series C Financing co-led by

  • 2023年05月18日
  • Author edit: mf123456

Boundless Bio announced the closing of a $100 million Series C financing co-led by Leaps by Bayer, the impact investment arm of Bayer AG, and RA Capital Management, with participation from additional new investors, Sectoral Asset Management and Piper Heartland Healthcare Capital. Boundless Bio will use the financing to advance BBI-355, the first ecDNA-directed therapy (ecDTx), through meaningful clinical readouts from its ongoing Phase 1/2 clinical trial in patients with oncogene-amplified cancers.

Read more ›
More